ScholarIQanswers from OpenAlex

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years

PaperCitations, authors & open-access status

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years have?

ScholarIQcitation count

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years has 313 citations in the OpenAlex counts ScholarIQ stores.

When was Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years published?

ScholarIQyear

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years has 2022 year in the ScholarIQ index.

What is the open-access status of Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years?

ScholarIQoa status

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years has diamond oa status in the ScholarIQ index.

What is the DOI of Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years?

ScholarIQdoi

The DOI for Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years is on the source record.

What is the PMID of Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years?

ScholarIQpmid

The PMID for Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years is on the source record.

What is the OpenAlex record for Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years?

ScholarIQopenalex

The OpenAlex for Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial